Report #2832337

Received Mar 20, 2025

A note on interpretation. VAERS reports are unverified and may be incomplete or coincidental. A report does not establish that a vaccine caused an event, and counts should not be used to calculate incidence or infer causation. Full disclaimer

Overview

Sex: Female
Age: 14 yrs
State: —
Recovered: Unknown
Vaccinated: Jun 20, 2017
Onset: Mar 27, 2019
Days to onset: 645
Hospital days: —

Vaccines (2)

Type	Name	Manufacturer	Dose	Lot	Route / Site
HPV9	HPV (GARDASIL 9)	MERCK & CO. INC.	1	—	—
HPV9	HPV (GARDASIL 9)	MERCK & CO. INC.	2	—	—

Symptoms (2)

Inappropriate schedule of product administrationNo adverse event

Symptom narrative

No additional adverse event; Consumer called to report they received their first dose of GARDASIL 9 on 06/20/2017 and their second dose was administered 03/27/2019.; This spontaneous report was received from a physician and refers to a 16-year-old female patient. The patient's medical history, current conditions and concomitant medications was not reported. On 20-JUN-2017 patient was vaccinated with first dose of Human Papillomavirus 9-valent Vaccine, Recombinant (GARDASIL®9), (lot # and expiration date were not reported) and the second dose on 27-MAR-2019 (inappropriate schedule of product administration). No additional adverse event. Lot number is being requested and will be submitted if received.